RT Journal Article SR Electronic T1 Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab JF Journal for ImmunoTherapy of Cancer JO J Immunother Cancer FD BMJ Publishing Group Ltd SP e002663 DO 10.1136/jitc-2021-002663 VO 9 IS 10 A1 Koguchi, Yoshinobu A1 Iwamoto, Noriko A1 Shimada, Takashi A1 Chang, Shu-Ching A1 Cha, John A1 Curti, Brendan D A1 Urba, Walter J A1 Piening, Brian D A1 Redmond, William L YR 2021 UL http://jitc.bmj.com/content/9/10/e002663.abstract AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.